Explore evidence

83 %HIV status disclosure to partners was reported in 83% of patients.

Sierra LeoneVIH/sidaobserved 2019-2020published 2021Global health actioneurope_pmcdocument of 4 observationsDOI 10.1080/16549716.2021.1947566

100 %There was a 100% decrease in HBV screening during January–June 2020 in Freetown, Sierra Leone.

Sierra Leonehépatite Bobserved January-June 2020published 2023Impact of COVID-19 on Hepatitis B Screening in Sierra Leone: Insights from a Community Phaeurope_pmcdocument of 8 observationsDOI 10.1101/2023.05.24.23290418

24.5 %Escherichia coli accounted for 24.5% of 49 bacterial isolates from surgical site infections.

Sierra Leonesurgical site infectionobserved February and July 2021published 2022Antimicrobial resistance and infection controleurope_pmcdocument of 15 observationsDOI 10.1186/s13756-022-01078-y

14.2 %The prevalence of left ventricular hypertrophy (LVH) by two-dimensional echo among adults in Freetown, Sierra Leone was 14.2%.

Sierra Leoneleft ventricular hypertrophyobserved 2019–2021published 2023BMJ openeurope_pmcdocument of 6 observations

8.2 %Among Enterobacteriaceae isolates, 8.2% were resistant to carbapenems.

Sierra Leonesurgical site infectionobserved February and July 2021published 2022Antimicrobial resistance and infection controleurope_pmcdocument of 15 observationsDOI 10.1186/s13756-022-01078-y

61.2 %Among 761 HIV-exposed infants (HEIs), 466 (61.2%) underwent their first virological test within 6–8 weeks of birth.

Sierra LeoneVIH/sidapublished 2026PLOS global public healtheurope_pmcdocument of 6 observations

27.6 %The indication for prescribing antibiotics was inappropriate in 252 (27.6%) patients.

Sierra Leonebacterial infectionobserved April 2022published 2023IJID regionseurope_pmcdocument of 2 observations

20.6 %Among pregnant women in Sierra Leone, K103N was found in 20.6% (n = 7/34) of cases.

Sierra LeoneVIH/sidapublished 2021Geneseurope_pmcdocument of 21 observationsDOI 10.3390/genes12091314

11.7 %Among 306 adult participants in Freetown, Sierra Leone, 11.7% were vaccinated against HBV.

Sierra Leonehépatite Bpublished 2023Healthcare (Basel, Switzerland)europe_pmcdocument of 5 observationsDOI 10.3390/healthcare11020177

0.001 p_valueThe p-value for the change in pre- and postoperative antibiotic use in caesarean section patients between 2021 and 2023 was less than 0.001.

Sierra Leonesurgical site infectionspublished 2023Tropical medicine and infectious diseaseeurope_pmcdocument of 5 observationsDOI 10.3390/tropicalmed8080385

43.8 %Procalcitonin was elevated in 43.8% of the articles on COVID-19 patients with sepsis or septic shock.

Sierra LeoneCOVID-19 · sepsis · septic shockpublished 2020Sepsis and septic shock in COVID-19: a scoping review of the research dataeurope_pmcdocument of 17 observationsDOI 10.21203/rs.3.rs-30474/v1

17.3 %About 17.3% of people with HIV in Freetown, Sierra Leone received at least one dose of a COVID-19 vaccine between April and June 2022.

Sierra LeoneCOVID-19 · VIH/sidaobserved April to June 2022published 2023Vaccineseurope_pmcdocument of 5 observationsDOI 10.3390/vaccines11111685

85,400 casesIn Sierra Leone, there are 85,400 annual cases of recurrent vulvovaginal candidiasis.

Sierra Leonerecurrent vulvovaginal candidiasispublished 2021Therapeutic advances in infectious diseaseeurope_pmcdocument of 9 observations

18.8 %Among children and adolescents in Sierra Leone, V108I was found in 18.8% (n = 12/64) of cases.

Sierra LeoneVIH/sidapublished 2021Geneseurope_pmcdocument of 21 observationsDOI 10.3390/genes12091314

5.9 %Among pregnant women in Sierra Leone, K219N/E/Q/R was found in 5.9% (n = 2/34) of cases.

Sierra LeoneVIH/sidapublished 2021Geneseurope_pmcdocument of 21 observationsDOI 10.3390/genes12091314

13.58 %Tuberculosis was diagnosed in 13.58% of young HIV patients aged 15 to 24 years at a major hospital in Sierra Leone.

Sierra Leonetuberculose · VIH/sidapublished 2023Prevalence and factors associated with advanced HIV disease among young people aged 15 - 2europe_pmcdocument of 8 observationsDOI 10.1101/2023.11.07.23296880

9.9 %The prevalence of obesity was 9.9% among males and 10.2% among females in Sierra Leone.

Sierra Leoneobésitépublished 2023Sex-and-gender differences in cardiovascular risk factors and their correlates among adulteurope_pmcdocument of 5 observations

69.6 %Postoperative antibiotic use for caesarean section patients was 69.6% in 2021.

Sierra Leonesurgical site infectionsobserved 2021published 2023Tropical medicine and infectious diseaseeurope_pmcdocument of 5 observationsDOI 10.3390/tropicalmed8080385

41.2 %In 2020, 2249 people were tested for HIV compared to 3825 in 2019, representing a reduction of 41.2%.

Sierra LeoneVIH/sidaobserved 2020published 2024AIDS and behavioreurope_pmcdocument of 7 observations

34 %Vomiting was present in 34% of patients with Ebola virus disease at presentation.

Sierra Leonemaladie à virus Ebolapublished 2014The New England journal of medicineeurope_pmcdocument of 14 observations

41.5 %Among 275 newly diagnosed people living with HIV (PWH) enrolled in the Sierra Leone HIV Cohort Study in Freetown from March to September 2021, 41.5% had at least one noncommunicable disease (NCD).

Sierra Leonenoncommunicable diseaseobserved March to September 2021published 2022Journal of clinical medicineeurope_pmcdocument of 9 observations

59,439 dosesThe median monthly uptake of total IPTp was 59,439 after COVID-19.

Sierra Leonepaludismepublished 2025Impact of the COVID-19 pandemic on the uptake of intermittent sulphadoxine-pyrimethamine feurope_pmcdocument of 5 observations

25 %Among children and adolescents in Sierra Leone, T215F/Y was found in 25.0% (n = 16/64) of cases.

Sierra LeoneVIH/sidapublished 2021Geneseurope_pmcdocument of 21 observationsDOI 10.3390/genes12091314

53.1 %Among healthcare professionals in Sierra Leone surveyed from January to March 2022, 53.1% reported concerns about profiteering or mistrust of health authorities regarding COVID-19 vaccines.

Sierra LeoneCOVID-19observed January to March 2022published 2022Vaccineseurope_pmcdocument of 12 observations

16 %Of the 8538 people tested for HIV in the three facilities, 1369 (16.0%) were positive for HIV.

Sierra LeoneVIH/sidapublished 2024AIDS and behavioreurope_pmcdocument of 7 observations